Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina

Veterans Administration Medical Center, Portland, Oregon.

The effectiveness of an intermittent regimen of transdermal nitroglycerin in chronic stable angina was evaluated in 206 patients using serial treadmill testing. After a placebo stabilization phase, patients were randomized to 4 weeks of double-blind treatment with transdermal nitroglycerin, 10 or 20 cm2 (equivalent to 5 or 10 mg/24 h) (Group A); transdermal nitroglycerin, 30 or 40 cm2 (equivalent to 15 or 20 mg/24 h) (Group B), or placebo. Patches were applied at 8:00 AM and removed at 8:00 PM each day throughout the study. Treadmill testing was performed 0, 4, 8 and 12 h after patch application at baseline (day 0) and on days 1, 15 and 29. After short-term application of the transdermal patches, treadmill walking time was greater for patients in both Group A and Group B than for the placebo group at all time points tested; differences from placebo were statistically significant at 12 h for Group A and at 4, 8 and 12 h for Group B. After 2 and 4 weeks of long-term therapy, treadmill walking time was again greater for Group B than for the placebo group at all postapplication time points; differences from placebo reached statistical significance at 4 h (2 weeks) and 8 h (2 and 4 weeks). The improvement in the treadmill walking time seen over the short-term in Group A was largely lost after 4 weeks of long-term therapy. Potentially important differences in the patient characteristics of the two active treatment groups, particularly the greater use of a beta-adrenergic blocker among patients in Group A, may have contributed to these observed differences in treatment effect. An unexpected finding was the ability of the placebo group to exercise longer than either active treatment group just before patch application during long-term therapy; nonetheless, absolute responsiveness to transdermal nitroglycerin after patch application remained virtually unchanged in both active treatment groups during the 4 week treatment period. Intermittent transdermal nitroglycerin therapy was well tolerated in the vast majority of patients; nine patients experienced an increase in nonexertional angina during the patch-off periods but completed the study uneventfully.

This article has been cited by other articles:

				T. Gori and J. D. Parker Nitrate-Induced Toxicity and Preconditioning: A Rationale for Reconsidering the Use of These Drugs J. Am. Coll. Cardiol., July 22, 2008; 52(4): 251 - 254. [Abstract] [Full Text] [PDF]

				U. Thadani Current Medical Management of Chronic Stable Angina Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S11 - S29. [Abstract] [PDF]

				J. George, I. Kitzis, D. Zandorf, M. Golovner, I. Shapira, S. Laniado, and A. Roth Safety of Nitrate Withdrawal in Angina-Free and Hemodynamically Stable Patients With Coronary Artery Disease Chest, November 1, 2003; 124(5): 1652 - 1657. [Abstract] [Full Text] [PDF]

				S. Muller, U. Laber, J. Mullenheim, W. Meyer, and G. Kojda Preserved endothelial function after long-term eccentric isosorbide mononitrate despite moderate nitrate tolerance J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1994 - 2000. [Abstract] [Full Text] [PDF]

				J. O. Parker, J. D. Parker, R. W. Caldwell, B. Farrell, and W. H. Kaesemeyer The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1199 - 1203. [Abstract] [Full Text] [PDF]

				D. A. Zvara Treatment of Perioperative Myocardial Ischemia Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2001; 5(2): 166 - 183. [Abstract] [PDF]

				E. R. Azevedo, A. M. Schofield, S. Kelly, and J. D. Parker Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine J. Am. Coll. Cardiol., February 1, 2001; 37(2): 505 - 509. [Abstract] [Full Text] [PDF]

				D. Hebert and J. Y. T. Lam Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2311 - 2316. [Abstract] [Full Text] [PDF]

				T. Munzel, H. Mollnau, M. Hartmann, C. Geiger, M. Oelze, A. Warnholtz, A. H. Yehia, U. Forstermann, and T. Meinertz Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production J. Am. Coll. Cardiol., August 1, 2000; 36(2): 628 - 634. [Abstract] [Full Text] [PDF]

				A. H. Zwinderman, T. J. Cleophas, H. van der Sluijs, M. G. Niemeyer, B. P. Buunk, E. E. van der Wall, T. J. Cleophas, and Dutch Mononitrate Quality of Life Study Group Comparison of 50-mg and 100-mg Sustained-Release Isosorbide Mononitrate in the Treatment of Stable Angina Pectoris: Effects on Quality-of-Life Indices Angiology, December 1, 1999; 50(12): 963 - 969. [Abstract] [PDF]

				P. R. A. Caramori, A. G. Adelman, E. R. Azevedo, G. E. Newton, A. B. Parker, and J. D. Parker Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1969 - 1974. [Abstract] [Full Text] [PDF]

				J. D. Parker and J. O. Parker Nitrate Therapy for Stable Angina Pectoris N. Engl. J. Med., February 19, 1998; 338(8): 520 - 531. [Full Text] [PDF]

				North of England Stable Angina Guideline Developme North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of stable angina BMJ, March 30, 1996; 312(7034): 827 - 832. [Full Text]

				J. O. Parker, M. H. Amies, R. W. Hawkinson, J. M. Heilman, A. J. Hougham, M. C. Vollmer, and R. R. Wilson Intermittent Transdermal Nitroglycerin Therapy in Angina Pectoris : Clinically Effective Without Tolerance or Rebound Circulation, March 1, 1995; 91(5): 1368 - 1374. [Abstract] [Full Text]

				J. Abrams The Role of Nitrates in Coronary Heart Disease Arch Intern Med, February 27, 1995; 155(4): 357 - 364. [Abstract] [PDF]

				J. D. Parker, A. B. Parker, B. Farrell, and J. O. Parker Intermittent Transdermal Nitroglycerin Therapy : Decreased Anginal Threshold During the Nitrate-Free Interval Circulation, February 15, 1995; 91(4): 973 - 978. [Abstract] [Full Text]

				U. Thadani Nitrate Therapy and the Development of Tolerance Arch Fam Med, August 1, 1993; 2(8): 880 - 885. [Abstract] [PDF]

				U. Elkayam Tolerance to Organic Nitrates: Evidence, Mechanisms, Clinical Relevance, and Strategies for Prevention Ann Intern Med, April 15, 1991; 114(8): 667 - 677. [Abstract] [PDF]

				INTERMITTENT USE OF TRANSDERMAL NITROGLYCERIN YIELDS MIXED RESULTS Journal Watch (General), April 4, 1989; 1989(404): 5 - 5. [Full Text]